Cargando…
Development and Validation of a Dried Blood Spot Assay Using UHPLC-MS/MS to Identify and Quantify 12 Antihypertensive Drugs and 4 Active Metabolites: Clinical Needs and Analytical Limitations
As nonadherence to antihypertensive drugs (AHDs) can increase the risk of cardiovascular events, hospitalization, and higher costs, there is a need for a reliable, objective, and easy method to assess nonadherence in patients. The dried blood spot (DBS) sampling method used to measure drug concentra...
Autores principales: | Peeters, Laura E. J., Bahmany, Soma, Dekker, Tim, Aliawi, Aya, van Domburg, Bart, Versmissen, Jorie, Koch, Birgit C. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Therapeutic Drug Monitoring
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275854/ https://www.ncbi.nlm.nih.gov/pubmed/35383727 http://dx.doi.org/10.1097/FTD.0000000000000984 |
Ejemplares similares
-
Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate—a validated assay for the clinic
por: Hooff, Gero P., et al.
Publicado: (2011) -
A Validated UHPLC–MS/MS Method to Quantify Eight Antibiotics in Quantitative Dried Blood Spots in Support of Pharmacokinetic Studies in Neonates
por: Liu, Qian, et al.
Publicado: (2023) -
A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots
por: Pigliasco, Federica, et al.
Publicado: (2021) -
Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant
por: Peeters, Laura E.J., et al.
Publicado: (2023) -
DiffErenCes in AntihypertenSive Drug Blood Levels in Patients with HypertensiON (DECISION): Protocol for a Prospective Observational Study Comparing Pharmacokinetics and Pharmacodynamics Between Young and Elderly Patients
por: Hassan, Dimokrat, et al.
Publicado: (2022)